Most Recent analysts Ratings: Synaptics Incorporated(NASDAQ:SYNA): Arena Pharmaceuticals, Inc.(NASDAQ:ARNA)

0
3

Synaptics Incorporated (SYNA) will report its next earnings on May 07 AMC. The company reported the earnings of $2.04/Share in the last quarter where the estimated EPS by analysts was $1.45/share. The difference between the expected and actual EPS was $0.59/share, which represents an Earnings surprise of 40.7%.

Many analysts are providing their Estimated Earnings analysis for Synaptics Incorporated and for the current quarter 9 analysts have projected that the stock could give an Average Earnings estimate of $1.41/share. These analysts have also projected a Low Estimate of $1.29/share and a High Estimate of $1.52/share.

These analysts also forecasted Growth Estimates for the Current Quarter for SYNA to be 181.6%. They are projecting Next Quarter growth of -10.66%. For the next 5 years, Synaptics Incorporated is expecting Growth of -26.46% per annum, whereas in the past 5 years the growth was 45.5% per annum.

Some buy side analysts are also providing their Analysis on Synaptics Incorporated, where 0 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.64 and Average Volume (3 months) is 697.69 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 13.21.

The company shows its Return on Assets (ROA) value of -1.2%. The Return on Equity (ROE) value stands at -2.6%. While it’s Return on Investment (ROI) value is -0.3%.

While looking at the Stock’s Performance, Synaptics Incorporated currently shows a Weekly Performance of 2.94%, where Monthly Performance is 0.38%, Quarterly performance is -10.4%, 6 Months performance is 11.35% and yearly performance percentage is 129.69%. Year to Date performance value (YTD perf) value is -3.19%. The Stock currently has a Weekly Volatility of 4.43% and Monthly Volatility of 5.05%.

Arena Pharmaceuticals, Inc. (ARNA) will report its next earnings on May 07 AMC. The company reported the earnings of $-1.76/Share in the last quarter where the estimated EPS by analysts was $-1.55/share. The difference between the expected and actual EPS was $-0.21/share, which represents an Earnings surprise of -13.5%.

Many analysts are providing their Estimated Earnings analysis for Arena Pharmaceuticals, Inc. and for the current quarter 12 analysts have projected that the stock could give an Average Earnings estimate of $-2.28/share. These analysts have also projected a Low Estimate of $-4.86/share and a High Estimate of $-1.35/share.

These analysts also forecasted Growth Estimates for the Current Quarter for ARNA to be -75%. They are projecting Next Quarter growth of -60.96%. For the next 5 years, Arena Pharmaceuticals, Inc. is expecting Growth of 34.11% per annum, whereas in the past 5 years the growth was -214.3% per annum.

Some buy side analysts are also providing their Analysis on Arena Pharmaceuticals, Inc., where 3 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.17 and Average Volume (3 months) is 671.41 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -27%. The Return on Equity (ROE) value stands at -29.3%. While it’s Return on Investment (ROI) value is 33.2%.

While looking at the Stock’s Performance, Arena Pharmaceuticals, Inc. currently shows a Weekly Performance of 6.87%, where Monthly Performance is 10.38%, Quarterly performance is 19.08%, 6 Months performance is 21.34% and yearly performance percentage is 6.55%. Year to Date performance value (YTD perf) value is 25.3%. The Stock currently has a Weekly Volatility of 5.95% and Monthly Volatility of 5.81%.

SHARE